Cidara’s Merck Merit: A Value Investor’s Dilemma

This is no mere pebble in the pond; it’s a stone that ripples. The $6.79 million stake, a sly whisper in the 13F report, swells to 1.66% of HighVista’s AUM. Their top five holdings, like a candy store of investments, include DBC, ABVX, MRUS, VRDN, and RVMD-each a sugary treat for the fund’s appetite.







